Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-21-000563
Filing Date
2021-06-17
Accepted
2021-06-17 09:21:26
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_7271.html 4  
1 PRIMARY DOCUMENT doc4_7271.xml 4 4285
  Complete submission text file 0001638599-21-000563.txt   5652
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Clasby Jennifer G (Reporting) CIK: 0001728919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 211023517